United States Eczema Therapeutics Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global Eczema Therapeutics Market is estimated to reach at a high CAGR during the forecast period (2024-2031).

Key Development:

United States: Recent Industry Developments

✅ In September 2025, the U.S. FDA approved LEO Pharma's delgocitinib cream (Anzupgo) for adults with moderate to severe chronic hand eczema (CHE), marking it as the first and only approved therapy for this condition in the U.S.

✅ In September 2025, the FDA expanded the approval of Incyte's Opzelura (ruxolitinib) cream to include pediatric patients aged 2 to 11 with atopic dermatitis, providing a non-steroidal treatment option for younger patients.

✅ In August 2025, Apogee Therapeutics launched a $300 million public offering to fund clinical trials and development of its eczema treatments, including APG777 and APG279, which aim to rival existing therapies like Dupixent.

Japan: Recent Industry Developments

✅ In October 2025, Japan Tobacco Inc. (JT) filed a New Drug Application for JTE-061 (generic name: tapinarof) cream 0.5%, a therapeutic aryl hydrocarbon receptor modulating agent, for the treatment of pediatric patients aged 2 to less than 12 years with atopic dermatitis.

✅ In August 2025, Astria Therapeutics entered into a licensing agreement with Kaken Pharmaceutical to develop and commercialize Navenibart for hereditary angioedema in Japan, expanding its presence in the Japanese market.

✅ In August 2025, Kyowa Kirin reported a 9% decrease in revenue from its Japan operations, primarily due to the termination of a sales partnership agreement for Dobovet, despite growth in other areas.

✅ In January 2025, Rohto Pharmaceutical announced plans to launch innovative medical products tailored to each country's regulatory environment, with the first launches expected within the next two to three years.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/eczema-therapeutics-market?sb

Eczema therapeutics are treatments aimed at managing and alleviating symptoms of eczema, a chronic inflammatory skin condition. They include corticosteroids, emollients, antihistamines, immunomodulators, and biologics to reduce inflammation, itching, and flare-ups while improving skin barrier function and patient quality of life.

Key Players:

=> Sanofi, Astellas Pharma, Anacor Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Meda AB, GlaxoSmithKline, AstraZeneca, Pfizer Inc., Hengrui Medicine, SYSVAX, and Hisun Pharmaceutical.

Growth Forecast Projected:

The Global Eczema Therapeutics Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Eczema Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=eczema-therapeutics-market

Key Segments:

➥ By Type of Treatment: Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics
➥ By End User: Hospitals & Retail Pharmacies, Drug Stores, Online/Mail Pharmacies

Regional Analysis for Eczema Therapeutics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Eczema Therapeutics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Eczema Therapeutics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/eczema-therapeutics-market?sb

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.